ONO-1110
/ Ono Pharmaceutical
- LARVOL DELTA
Home
Next
Prev
1 to 14
Of
14
Go to page
1
March 25, 2026
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
(clinicaltrials.gov)
- P2 | N=160 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting
Enrollment closed • Fibromyalgia • Musculoskeletal Pain • Pain • Rheumatology
March 03, 2026
ONO-1110-04: A Study of ONO-1110 in Patients With Postherpetic Neuralgia
(clinicaltrials.gov)
- P2 | N=140 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting
Enrollment closed • Neuralgia • Pain
February 21, 2026
A Study of ONO-1110 in Patients With Social Anxiety Disorder
(clinicaltrials.gov)
- P2 | N=100 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting
Enrollment closed • CNS Disorders • Mood Disorders • Psychiatry • Social Anxiety Disorder
February 21, 2026
A Study of ONO-1110 in Patients With Major Depressive Disorder
(clinicaltrials.gov)
- P2 | N=100 | Active, not recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Recruiting ➔ Active, not recruiting
Enrollment closed • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
March 18, 2025
A Study of ONO-1110 in Patients With Major Depressive Disorder
(clinicaltrials.gov)
- P2 | N=100 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
March 19, 2025
A Study of ONO-1110 in Patients With Social Anxiety Disorder
(clinicaltrials.gov)
- P2 | N=100 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • CNS Disorders • Mood Disorders • Psychiatry • Social Anxiety Disorder
February 21, 2025
A Study of ONO-1110 in Patients With Postherpetic Neuralgia
(clinicaltrials.gov)
- P2 | N=140 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Neuralgia • Pain
February 21, 2025
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
(clinicaltrials.gov)
- P2 | N=160 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Fibromyalgia • Musculoskeletal Pain • Pain • Rheumatology
February 11, 2025
A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis
(clinicaltrials.gov)
- P2 | N=50 | Recruiting | Sponsor: Ono Pharmaceutical Co. Ltd | Not yet recruiting ➔ Recruiting
Enrollment open • Interstitial Cystitis
February 03, 2025
A Study of ONO-1110 in Patients With Social Anxiety Disorder
(clinicaltrials.gov)
- P2 | N=100 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd
New P2 trial • CNS Disorders • Mood Disorders • Psychiatry • Social Anxiety Disorder
January 24, 2025
A Study of ONO-1110 in Patients With Major Depressive Disorder
(clinicaltrials.gov)
- P2 | N=100 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd
New P2 trial • CNS Disorders • Depression • Major Depressive Disorder • Mood Disorders • Psychiatry
January 04, 2025
A Clinical Study of ONO-1110 in Patients With Fibromyalgia
(clinicaltrials.gov)
- P2 | N=160 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd
New P2 trial • Fibromyalgia • Musculoskeletal Pain • Pain • Rheumatology
January 04, 2025
A Clinical Study of ONO-1110 in Patients With Hunner Type Interstitial Cystitis
(clinicaltrials.gov)
- P2 | N=50 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd
New P2 trial • Interstitial Cystitis
November 27, 2024
A Study of ONO-1110 in Patients With Postherpetic Neuralgia
(clinicaltrials.gov)
- P2 | N=140 | Not yet recruiting | Sponsor: Ono Pharmaceutical Co. Ltd
New P2 trial • Neuralgia • Pain
1 to 14
Of
14
Go to page
1